Glucose and insulin levels after six months of treatment with a triphasic oral contraceptive containing ethinyl estradiol and norethindrone.
A prospective study of carbohydrate metabolism was done on 33 women who used a triphasic oral contraceptive (OC) containing ethinyl estradiol and norethindrone for six months. A three-hour oral glucose tolerance test was administered before and after the OC usage, and both the blood glucose and insulin levels were determined. A significant decrease in the fasting glucose level was found with treatment. All other glucose values and insulin levels were unchanged.
Spellacy
W N
WN
Department of Obstetrics and Gynecology, University of Illinois College of Medicine, Chicago.
Ellingson
A B
AB
Tsibris
J C
JC
D000328:Adult; D001786:Blood Glucose / Q000378:metabolism*; D003276:Contraceptives, Oral / Q000494:pharmacology*; D003279:Contraceptives, Oral, Sequential / Q000494:pharmacology*; D004997:Ethinyl Estradiol / Q000008:administration & dosage* / Q000494:pharmacology; D005260:Female; D006801:Humans; D007328:Insulin / Q000097:blood*; D009640:Norethindrone / Q000008:administration & dosage* / Q000494:pharmacology; D011446:Prospective Studies
D001786:Blood Glucose; D003276:Contraceptives, Oral; D003279:Contraceptives, Oral, Sequential; D007328:Insulin; D004997:Ethinyl Estradiol; D009640:Norethindrone